33 min listen
BridgeBio's Chief Regulatory Affairs Officer Adora Ndu on PDUFA VII Reauthorization
BridgeBio's Chief Regulatory Affairs Officer Adora Ndu on PDUFA VII Reauthorization
ratings:
Length:
28 minutes
Released:
Oct 13, 2022
Format:
Podcast episode
Description
On the heels of Congress' reauthorization of the Prescription Drug User Fee Authorization (PDUFA) Act, BridgeBio's Chief Regulatory Affairs Officer, Adora Ndu, explains the Commitment Letter, the programs that may be rolled out under PDUFA VII, why right-sizing CBER will help the cell and gene sector going forward as well as how sponsor companies can prepare for 2023 from a regulatory perspective.
Released:
Oct 13, 2022
Format:
Podcast episode
Titles in the series (77)
Cellevolve Bio's Dr. Derrell Porter on the Need for Diversity and Inclusion in Biotech by Cell & Gene: The Podcast